Skip to main content

AIGO — Risk Schema Documentation

1. Document Purpose

This document describes the machine-readable AIGO Risk Schema. The schema provides the structured representation of AI-related risks governed under the AIGO AI Governance Operating Framework. It is intended to support:
  • AI risk identification;
  • risk description and categorization;
  • risk source and context;
  • affected stakeholders and assets;
  • likelihood and impact assessment;
  • inherent and residual risk;
  • risk treatment;
  • risk ownership;
  • control relationships;
  • risk acceptance;
  • monitoring;
  • escalation;
  • reassessment;
  • incident and change relationships;
  • assurance; and
  • risk closure.
The JSON schema defines structural requirements. This documentation explains the intended meaning and governance use of those structures.

2. Schema Information


3. Scope

The Risk Schema applies to risks arising from AI systems, AI-enabled activities, governance arrangements, supporting processes, data, models, technology, people, suppliers, and other relevant conditions within the organization’s AIGO scope. The schema may represent:
  • strategic risks;
  • governance risks;
  • operational risks;
  • technical risks;
  • model risks;
  • data risks;
  • security risks;
  • privacy risks;
  • fairness and discrimination risks;
  • safety risks;
  • human-oversight risks;
  • compliance risks;
  • third-party risks;
  • lifecycle risks; and
  • emerging risks.
The organization’s approved risk methodology determines which risks are required to be recorded and how they are evaluated.

4. Object Model

The primary object represented by this schema is:
A Risk record represents a defined risk requiring governance attention. The record should remain distinct from:
  • an AI System record;
  • a Control record;
  • an Assessment record;
  • an Approval record;
  • an Incident record;
  • a Change record;
  • an Assurance record; and
  • an Evidence record.
Related records should normally be connected through stable identifiers.

5. Core Identity

A Risk record should contain stable identity information. Key fields include:
  • id;
  • objectType;
  • objectVersion;
  • schemaVersion;
  • risk title or description;
  • risk owner;
  • risk status; and
  • assessment information.
Example:
The risk identifier should remain stable while the risk record is maintained. A materially distinct risk should normally receive a distinct identifier.

6. Risk Statement

The risk record should describe the risk clearly enough for governance stakeholders to understand:
  • the source or cause;
  • the event or condition;
  • the potential consequence;
  • the affected context;
  • the relevant AI system or activity; and
  • the reason the risk requires governance attention.
A useful risk statement generally connects a cause or condition with a possible consequence. For example:
The specific wording should follow the organization’s approved risk methodology.

7. Risk Categories

The schema supports categorization of risk. Possible categories include:
  • governance;
  • strategic;
  • legal or regulatory;
  • compliance;
  • operational;
  • financial;
  • reputational;
  • technical;
  • model;
  • data;
  • security;
  • privacy;
  • fairness;
  • discrimination;
  • safety;
  • reliability;
  • human oversight;
  • transparency;
  • explainability;
  • third-party;
  • change;
  • lifecycle; and
  • other organization-defined categories.
Organizations may maintain a controlled taxonomy aligned to their risk methodology.

8. Risk Source and Context

The risk record should capture the context in which the risk arises. This may include:
  • AI system;
  • business process;
  • lifecycle stage;
  • data source;
  • model;
  • technology component;
  • supplier;
  • human decision process;
  • governance process;
  • external environment;
  • regulatory development; or
  • incident or change.
Context information helps ensure that risk treatment addresses the underlying source of risk rather than only its symptoms.

9. AI System Relationship

Where a risk relates to an AI system, the risk should reference the relevant AI System record. Example:
A single AI system may have multiple risks. A single risk may also affect multiple systems where the risk is enterprise-wide or shared. The risk record remains authoritative for the risk analysis and treatment.

10. Stakeholder and Affected-Person Context

Risk identification should consider who may be affected. Relevant stakeholders may include:
  • customers;
  • employees;
  • users;
  • applicants;
  • suppliers;
  • business partners;
  • regulators;
  • members of the public; and
  • other affected persons or groups.
The risk record may identify:
  • affected stakeholder groups;
  • affected persons;
  • potential harms;
  • business effects;
  • rights or interests potentially affected; and
  • stakeholder significance.
This information supports proportional risk evaluation.

11. Risk Lifecycle

A risk should move through a controlled governance lifecycle. A typical risk lifecycle is:
The organization’s risk procedure governs actual transitions. The schema represents the state but does not authorize the transition.

12. Risk Status

The exact status enumeration defined in the JSON schema is authoritative. Typical risk states may include:
The organization should use status values consistently across its risk repository.

13. Inherent Risk

Inherent risk represents risk before considering the effectiveness of implemented risk treatments or controls, according to the organization’s methodology. The risk record may capture:
  • likelihood;
  • impact;
  • inherent risk level;
  • risk rationale; and
  • assessment date.
The underlying scoring model should be documented through the organization’s risk methodology rather than inferred from the schema alone.

14. Likelihood

Likelihood represents the organization’s assessment of how probable the risk event or condition is within the applicable context. Depending on the organization’s methodology, likelihood may be represented as:
  • qualitative level;
  • numerical value;
  • probability range;
  • frequency;
  • scenario-based assessment; or
  • another approved measure.
The schema should preserve the organization’s defined representation without changing its semantic meaning.

15. Impact

Impact represents the significance of potential consequences if the risk materializes. Impact may consider:
  • people;
  • safety;
  • privacy;
  • fairness;
  • security;
  • financial consequences;
  • operational disruption;
  • legal or regulatory consequences;
  • reputation;
  • customer impact;
  • business continuity; and
  • other material effects.
Impact should be evaluated using the approved AIGO risk methodology.

16. Risk Level

The schema uses the common AIGO RiskLevel definition. Risk levels should be interpreted consistently throughout the AIGO schema ecosystem. A typical conceptual scale may include:
The authoritative enumeration is defined by the common definitions schema. Risk level should not be assigned solely through intuition or unsupported judgment.

17. Risk Evaluation

Risk evaluation determines whether the assessed risk is:
  • acceptable;
  • tolerable subject to conditions;
  • requires treatment;
  • above organizational tolerance;
  • requires escalation; or
  • otherwise requires governance action.
Evaluation should consider the organization’s:
  • risk appetite;
  • risk tolerance;
  • regulatory obligations;
  • affected-person impacts;
  • control environment;
  • stakeholder expectations; and
  • strategic context.

18. Risk Appetite and Tolerance

Risk records may reference the organization’s applicable:
  • risk appetite;
  • risk tolerance;
  • risk thresholds;
  • escalation thresholds; and
  • acceptance authority.
The risk record should not establish organizational risk appetite independently. Those requirements should come from the organization’s governance arrangement.

19. Risk Treatment

A risk treatment describes how the organization intends to modify the risk. Typical treatment strategies include:
  • avoid;
  • reduce;
  • control;
  • transfer;
  • share;
  • accept;
  • restrict;
  • suspend; or
  • retire.
The organization should define treatment terminology through its approved methodology. A treatment should normally identify:
  • treatment action;
  • responsible owner;
  • target date;
  • required controls;
  • dependencies;
  • status; and
  • evidence.

20. Treatment Actions

Treatment actions should be explicit and accountable. Example:
Treatment should address the identified cause or consequence of the risk where practical.

21. Control Relationships

Risks may be treated through one or more controls. The risk record should reference control identifiers rather than duplicating the full control definition. Example:
Control effectiveness remains authoritative in the Control and Control Assessment records.

22. Residual Risk

Residual risk represents the remaining risk after considering implemented controls and treatments. The record may include:
  • residual risk level;
  • residual risk rationale;
  • remaining consequences;
  • outstanding treatments;
  • acceptance requirement;
  • escalation requirement; and
  • monitoring requirements.
Residual risk should not automatically equal the inherent risk.

23. Risk Acceptance

Risk acceptance is a controlled governance decision. Where required, the risk record should reference the formal risk acceptance record. An acceptance should identify:
  • accepted risk;
  • residual risk;
  • acceptance authority;
  • decision date;
  • validity period;
  • conditions;
  • rationale; and
  • review or expiry requirements.
A risk should not be treated as accepted merely because an individual enters "ACCEPTED" into a status field. Formal acceptance should be governed through the applicable AIGO procedure and authority.

24. Risk Escalation

A risk should be escalated when applicable thresholds are exceeded. Potential escalation triggers include:
  • residual risk above tolerance;
  • risk involving critical safety concerns;
  • significant privacy or security impact;
  • material fairness or discrimination concerns;
  • unresolved control failures;
  • repeated incidents;
  • regulatory concerns;
  • significant stakeholder impact;
  • inability to implement required treatment; or
  • management review direction.
The organization’s governance model determines escalation authority.

25. Risk Monitoring

A risk may require ongoing monitoring. Monitoring can address:
  • key risk indicators;
  • control performance;
  • residual risk;
  • incident trends;
  • model or data changes;
  • stakeholder impacts;
  • regulatory developments;
  • treatment progress; and
  • emerging risk indicators.
Monitoring requirements should be connected to the Monitoring schema where a formal monitoring plan is required.

26. Risk Reassessment

Risk should be reassessed when relevant conditions change. Potential reassessment triggers include:
  • material AI system changes;
  • model changes;
  • data changes;
  • changes in intended purpose;
  • changes in operating context;
  • significant incidents;
  • control failures;
  • monitoring threshold breaches;
  • regulatory changes;
  • changes in stakeholder impact;
  • changes in risk appetite; and
  • management review decisions.
Reassessment should preserve the relationship between the previous and new risk evaluations.

27. Incident Relationship

An incident may create, modify, increase, or reveal a risk. The risk record may therefore reference incident records. Example:
Incident records remain authoritative for:
  • detection;
  • investigation;
  • containment;
  • root cause;
  • impact;
  • corrective action; and
  • incident closure.
The risk record should capture the resulting risk implications.

28. Change Relationship

Changes to an AI system may introduce new risks or alter existing risks. The Risk record should support traceability to relevant change records. Example:
A material change should trigger risk reassessment where required by the organization’s change-management process.

29. Assessment Relationships

The risk record may reference assessment records supporting:
  • initial assessment;
  • reassessment;
  • impact assessment;
  • security assessment;
  • privacy assessment;
  • fairness assessment;
  • control assessment;
  • technical assessment; and
  • post-incident assessment.
The assessment record remains authoritative for assessment methodology, result, findings, and supporting evidence.

30. Assurance Relationships

Risk management may be subject to assurance. Assurance activities may evaluate:
  • risk identification;
  • risk analysis;
  • risk evaluation;
  • treatment;
  • residual risk;
  • acceptance;
  • monitoring; and
  • escalation.
The risk record should reference assurance records where applicable.

31. Evidence Relationships

Evidence may support virtually every stage of risk management. Examples include:
  • risk assessments;
  • testing results;
  • stakeholder analysis;
  • control evidence;
  • monitoring results;
  • incident evidence;
  • approval records;
  • assurance findings;
  • treatment completion evidence; and
  • acceptance decisions.
Evidence should normally be maintained as independent records and referenced by identifier.

32. Risk Dependencies

Risks may depend on other risks. For example:
Dependency relationships should be recorded where they are material to risk treatment or governance decisions. This is particularly important for systemic and portfolio-level AI risks.

33. Aggregated and Systemic Risk

Organizations may need to manage risks that emerge across multiple AI systems. Examples include:
  • common model-provider dependence;
  • common data-source failures;
  • shared cybersecurity vulnerabilities;
  • common fairness concerns;
  • concentration risk;
  • shared infrastructure dependencies; and
  • organization-wide governance weaknesses.
A systemic risk should be capable of referencing multiple AI systems and related governance records.

34. Emerging Risk

AIGO should support risks that are not yet fully characterized. An emerging risk may contain:
  • preliminary risk statement;
  • uncertain likelihood;
  • uncertain impact;
  • initial evidence;
  • monitoring requirements;
  • assigned owner;
  • review date; and
  • trigger conditions for formal reassessment.
The absence of precise quantification should not prevent an emerging risk from being governed.

35. Risk Treatment Effectiveness

Risk treatment should be evaluated after implementation. Evaluation may determine whether:
  • risk was reduced;
  • risk remained unchanged;
  • risk increased;
  • treatment was partially effective; or
  • effectiveness cannot yet be determined.
Where treatment is ineffective, further treatment, reassessment, escalation, or other governance action may be required.

36. Risk Closure

A risk should be closed only when the organization’s closure criteria have been satisfied. Possible closure conditions include:
  • risk no longer exists;
  • risk has been eliminated;
  • system has been retired;
  • risk has been transferred appropriately;
  • risk has been incorporated into another controlled risk;
  • applicable treatment is complete and no residual risk remains requiring separate tracking; or
  • another formally approved closure condition applies.
Closure should be supported by evidence and appropriate authority.

37. Risk Transfer

Where risk is transferred or shared, the risk record should maintain traceability to:
  • receiving party;
  • contractual arrangement;
  • transferred responsibilities;
  • retained residual exposure;
  • monitoring;
  • supplier governance; and
  • review requirements.
Risk transfer does not necessarily eliminate the organization’s accountability.

38. Third-Party Risks

Third-party AI services may introduce risks concerning:
  • service availability;
  • model behavior;
  • data handling;
  • privacy;
  • security;
  • intellectual property;
  • transparency;
  • change notification;
  • assurance;
  • contractual obligations; and
  • supplier concentration.
Such risks should remain explicitly assigned to accountable owners. Supplier relationships should be connected to relevant third-party governance records.

39. Risk and Human Oversight

Where human oversight is a risk treatment or risk factor, the risk record should identify the relevant relationship. Examples include risks arising from:
  • inadequate human review;
  • insufficient competence;
  • automation bias;
  • unclear override authority;
  • delayed escalation;
  • ineffective challenge mechanisms; or
  • inappropriate delegation.
Relevant controls and oversight arrangements should be referenced rather than duplicated.

40. Risk and Affected Persons

For risks affecting people, the organization should consider:
  • severity of potential harm;
  • scale of affected persons;
  • vulnerability;
  • reversibility;
  • duration;
  • likelihood;
  • ability to detect harm;
  • ability to contest decisions; and
  • available remediation.
These factors may influence classification, treatment, escalation, monitoring, and approval.

41. Risk and Regulatory Requirements

An AI risk may arise directly from external obligations. The risk record may reference:
  • applicable legal requirements;
  • regulatory requirements;
  • standards;
  • contractual obligations;
  • internal policy requirements; and
  • external commitments.
External framework mappings should remain authoritative for detailed requirement mappings. Relevant mapping repositories include:

42. Risk Reporting

Risk records may be aggregated into governance reporting. Reports may include:
  • total open risks;
  • risk distribution;
  • highest risks;
  • risks above tolerance;
  • overdue treatments;
  • accepted risks;
  • emerging risks;
  • systemic risks;
  • changes in risk profile;
  • risk trends; and
  • risk-treatment performance.
Reporting should preserve the distinction between source records and aggregated reporting views.

43. Risk Metrics

Organizations may define risk metrics such as: Metrics should have defined owners, formulas, thresholds, and review frequency where used.

44. Validation Requirements

A valid Risk record should satisfy:

Structural Validation

The JSON document must validate against: 02-AIGO-Risk-Schema-v0.1.json

Reference Validation

Referenced AI systems, controls, assessments, incidents, changes, assurances, approvals, evidence, and other records should exist where required.

Governance Validation

The record should follow the approved AIGO risk methodology and procedures.

Ownership Validation

Each active risk should have an accountable risk owner.

Treatment Validation

Risks requiring treatment should have appropriately assigned treatment actions.

Acceptance Validation

Accepted residual risks should have appropriate authority and evidence where formal acceptance is required.

Traceability Validation

Risk decisions should remain traceable to supporting assessments, controls, evidence, approvals, and monitoring.

45. Schema Limitations

JSON Schema does not independently determine whether:
  • the risk statement is substantively correct;
  • the scoring method is appropriate;
  • the likelihood assessment is accurate;
  • the impact assessment is reasonable;
  • the risk owner has sufficient authority;
  • the treatment is effective;
  • the organization has acceptable residual risk; or
  • regulatory obligations have been satisfied.
Those matters require human judgment, governance processes, evidence, and assurance.

46. Relationship to Templates

The Risk Schema corresponds primarily to the AIGO AI Risk Assessment Template and related risk records. Relevant template: guidance/03-templates/05-AIGO-AI-Risk-Assessment-Template-v0.1.md The template provides the human-readable operational record structure. The JSON schema provides the machine-readable representation.

47. Relationship to Procedures

The schema should be used with: guidance/02-procedures/03-AIGO-AI-Risk-Assessment-Procedure-v0.1.md and, where applicable:
  • AI classification;
  • control assessment;
  • approval;
  • monitoring;
  • incident management;
  • change management;
  • risk acceptance;
  • assurance;
  • continuous improvement; and
  • retirement procedures.
The procedure defines how the risk record is created, assessed, treated, accepted, monitored, escalated, reassessed, and closed.

48. Relationship to Framework Components


49. Risk Traceability Model

The recommended traceability chain is:
Additional relationships may connect the risk to:
This structure supports end-to-end governance traceability.

50. Example Record

A conceptual Risk record may look like:
The actual record must conform to the authoritative JSON schema.

51. Schema Registry Relationship

This schema is registered in: schemas/00-AIGO-Schema-Registry-v0.1.json The registry should maintain:
  • schema identifier;
  • object type;
  • version;
  • controlled path;
  • status;
  • dependencies;
  • referenced schemas;
  • owner;
  • documentation path; and
  • traceability metadata.

52. Change and Version Management

Changes to the Risk Schema should be controlled through the AIGO change-management process. Potential impacts should be assessed against:
  • existing risk records;
  • reporting;
  • assessment processes;
  • risk acceptance;
  • control relationships;
  • monitoring;
  • assurance;
  • external mappings;
  • validation tooling; and
  • downstream integrations.
Breaking changes should include migration guidance where necessary.

53. Future Extensions

Future versions may expand support for:
  • quantitative risk models;
  • probabilistic risk;
  • scenario analysis;
  • harm taxonomies;
  • systemic risk;
  • portfolio risk;
  • risk aggregation;
  • automated risk scoring;
  • risk heatmaps;
  • risk treatment effectiveness metrics; and
  • machine-readable external regulatory requirements.
Extensions should remain compatible with the core AIGO risk model.

54. Document Control


55. Document Status

Document: AIGO — Risk Schema Documentation Version: 0.1 Status: Draft Working Name: AIGO Full Name: AI Governance Operating Framework Document Identifier: AIGO-SCHEMA-DOC-002 Document Type: Schema Documentation This document provides the human-readable interpretation, governance context, validation expectations, and traceability guidance for the AIGO Risk Schema. End of Document